GT Biopharma Inc (GTBP.O)

+ 收藏

财务摘要(报告期)(GT Biopharma Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -3.86-1.64-5.64-0.12-0.06-0.01-0.66-0.48-0.26-0.17
 每股净资产(元) 2.473.850.180.240.290.350.360.490.500.55
 每股经营现金净流量(元) -3.45-3.02-0.21-0.16-0.12-0.08-0.47-0.34-0.26-0.16
 每股现金流量净额(元) 3.660.63-0.11-0.07-0.07-0.10-0.10-0.20-0.12-0.05
盈利能力:
 净资产收益率平均(%) -92.05-35.44-79.09-42.64-18.89-1.83-124.15-80.82-45.08-27.41
 总资产净利率(%) -51.13-18.87-49.26-28.19-12.72-1.23-85.41-57.48-29.89-18.25
 投入资本回报率ROIC(%) -91.60-21.59-63.06-37.74-16.78-1.56-121.90-73.19-40.08-25.10
收益质量:
 营业利润/利润总额(%) 117.09136.41178.70224.55328.351,614.54101.79101.17100.44100.04
资本结构:
 资产负债率(%) 40.5646.4147.0138.0435.1735.0129.8924.2836.1235.17
 权益乘数 1.681.871.891.611.541.541.431.321.571.54
 产权比率 0.680.870.890.610.540.540.430.320.570.54
 流动资产/总资产(%) 100.0099.7399.6299.4199.3299.2698.9699.0699.0899.10
 非流动资产/总资产(%) -0.270.380.590.680.741.040.940.920.90
 流动负债/负债合计(%) 100.00100.00100.0082.8675.9057.9698.7298.2098.6398.48
 非流动负债/负债合计(%) ---17.1424.1042.041.281.801.371.52
 归属母公司股东的权益/投入资本(%) 30,600.0066.7257.3874.1176.5072.35106.0685.7582.0888.27
偿债能力:
 流动比率 2.472.152.123.153.724.893.354.152.782.86
 速动比率 2.472.152.123.153.724.893.354.152.782.86
 货币资金/流动负债(%) 246.0542.3916.2752.0257.1350.17114.8649.0562.2376.67
 营业利润/流动负债(%) -186.14-67.20-204.67-204.48-150.44-89.92-430.48-308.04-98.21-57.27
 经营活动产生的现金流量净额/流动负债(%) -204.82-90.50-133.45-133.69-99.96-71.30-308.16-217.29-92.93-54.88
 归属母公司股东的权益/负债合计(%) 146.53115.48112.71162.87184.34185.61234.59311.78176.86184.34
 经营活动产生的现金流量净额/负债合计(%) -204.82-90.50-133.45-110.78-75.87-41.32-304.22-213.39-91.65-54.04
 营业利润/负债合计(%) -186.14-67.20-204.67-169.43-114.18-52.11-424.97-302.50-96.86-56.39
成长能力:
 总资产同比增长率(%) -48.93-50.65-15.70-23.36-24.93-26.80-47.97-41.14-38.91-0.74
 每股净资产同比增长率(%) 751.69987.07-49.74-50.78-42.46-35.64-47.53-53.28-61.17-53.35
 总负债同比增长率(%) -41.09-34.5932.6120.05-26.91-27.12-51.2430.47166.48166.13
 基本每股收益同比增长率(%) -129.76-680.9571.3175.0076.9294.1267.9668.8381.2990.71
 归属母公司股东的权益同比增长率(%) -53.18-59.31-36.29-37.29-23.81-26.62-46.44-50.21-57.65-26.45
 营业利润同比增长率(%) 3.9715.6636.1332.7613.8432.6563.0460.6574.6781.24
 股东权益合计同比增长率(%) -53.18-59.31-36.29-37.29-23.81-26.62-46.44-49.95-57.46-25.93
营运能力:
衍生指标:
 现金及现金等价物净增加额TTM(元) 6,482,000.00-95,000.00-4,593,000.00183,000.00-2,591,000.00-5,241,000.00-3,296,000.00-7,217,000.00-34,147,000.00-20,269,000.00
 利润总额TTM(元) -11,354,000.00-9,636,000.00-7,597,000.00-10,219,000.00-14,684,000.00-15,671,000.00-20,884,000.00-33,322,000.00-31,894,000.00-33,776,000.00
 投入资本(元) 18,000.007,962,000.0013,030,000.0013,500,000.0015,377,000.0018,042,000.0011,064,000.0018,606,000.0018,812,000.0020,153,000.00
 经营活动产生的现金流量净额TTM(元) -11,710,000.00-10,109,000.00-8,852,000.00-11,103,000.00-12,057,000.00-12,908,000.00-15,217,000.00-14,624,000.00-15,635,000.00-17,137,000.00
 归属母公司净利润TTM(元) -11,354,000.00-9,636,000.00-7,597,000.00-10,219,000.00-14,684,000.00-15,671,000.00-20,884,000.00-33,322,000.00-31,894,000.00-33,776,000.00

前瞻产业研究院